weight loss drug semaglutide Weight-Loss Wegovy Exceeded Expectations, and Supply A big win for Wegovy:
Description
The fairer comparison arrives once zenagamtide's Phase 3 programs report likely 2027 or later for the diabetes indication
0.56] and 1.09% [95% CI 1.28
References Wegovy (semaglutide 2.4 mg) Prescribing Information U.S
In the past, to lose weight, you needed to be under calorie restriction and you really needed to starve. The big change with GLP-1 is that you can eat normally and youre going to lose weight, so thats a big change. Monitoring will continue into, and probably beyond, 2026
